Activation and function of natural killer cell responses during viral infections

Current Opinion in Immunology

Volumn 9, Issue 1, 1997, Pages 24-34

  Biron, Christine A ^a  

^a Division of Biology and Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; GAMMA INTERFERON;

CELL MEDIATED CYTOTOXICITY; CYTOTOXICITY; EXPERIMENTAL INFECTION; IMMUNE RESPONSE; KILLER CELL; LYMPHOCYTE TRANSFORMATION; NATURAL KILLER CELL; REVIEW; VIRUS INFECTION;

EID: 0031019163     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(97)80155-0     Document Type: Article

References (91)

1. Biron CA, Gazzinelli RT. Effects of IL-12 on immune responses to microbial infections: a key mediator in regulating disease outcome. of special interest Curr Opin Immunol. 7:1995;485-496 Review of studies on IL-12 expression and function in viral, bacterial, and parasitic infections.
2. Trinchieri G. Biology of natural killer cells. Adv Immunol. 47:1989;187-376.
3. Welsh RM. Natural cell-mediated immunity during viral infections. Curr Topics Microb Immunol. 92:1986;83-106.
4. Biron CA. Cytokines in the generation of immune responses to, and resolution of, virus infection. Curr Opin Immunol. 6:1994;530-538.
5. Biron CA, Su HC, Orange JS. Function and regulation of natural killer (NK) cells during viral infections: characterization of responses in vivo. of special interest Methods: A Companion to Methods in Enzymology. 9:1996;379-393 Summary comparison of LCMV and MCMV infection models and their use for in vivo NK cell regulation and function studies.
6. Yokoyama WM. Right-side-up and up-side-down NK cell-receptors. of special interest Curr Biol. 5:1995;895-982 Recent review of NK cell recognition molecules.
7. Colonna M. Natural killer cell receptors specific for MHC class I molecules. of special interest Curr Opin Immunol. 8:1996;101-107 Recent review of NK cell recognition molecules.
8. + T cells. Curr Opin Immunol. 7:1995;367-374.
9. Trinchieri G, Santoli D, Koprowski H. Spontaneous cell-mediated cytotoxicity in humans: role of interferon and immunoglobulins. J Immunol. 120:1978;1849-1855.
10. Santoli D, Trinchieri G, Koprowski H. Cell-mediated cytotoxicity against virus-infected target cells in humans. II. Interferon induction and activation of natural killer cells. J Immunol. 121:1978;532-538.
11. Gidlund M, Örn A, Wigzell H, Senik A, Gresser I. Enhanced NK cell activity in mice injected with interferon and interferon inducers. Nature. 273:1978;759-761.
12. Welsh RM, Zinkernagel RM. Heterospecific cytotoxic cell activity induced during the first three days of acute lymphocytic choriomeningitis virus infection in mice. Nature. 268:1977;646-648.
13. Welsh RM. Cytotoxic cells induced during lymphocytic choriomeningitis virus infection of mice. I. Characterization of natural killer cell induction. J Exp Med. 148:1978;163-181.
14. Shellam GR, Allan JE, Paradimitriou JM, Bancroft GJ. Increased susceptibility to cytomegalovirus infection in beige mutant mice. Proc Natl Acad Sci USA. 78:1981;5104-5108.
15. Bancroft GJ, Shellam GR, Chalmer JE. Genetic influences on the augmentation of natural killer (NK) cells during murine cytomegalovirus infection: correlation with patterns of resistance. J Immunol. 126:1981;988-994.
16. Grundy (Chalmer) JE, Trapman J, Allan JE, Shellam GR, Melief CJM. Evidence for a protective role of interferon in resistance to murine cytomegalovirus and its control by non-H-2-linked genes. Infect Immun. 37:1982;143-150.
17. Bukowski JF, Woda BA, Habu S, Okumura K, Welsh RM. Natural killer cell depletion enhances virus synthesis and virus-induced hepatitis in vivo. J Immunol. 131:1983;1531-1538.
18. Bukowski JF, Woda BA, Welsh RM. Pathogenesis of murine cytomegalovirus infection in natural killer cell-depleted mice. J Virol. 52:1984;119-128.
19. Habu S, Akamatsu K, Tamaoki N, Okumura K. In vivo significance of NK cells on resistance against virus (HSV-1) infections in mice. J Immunol. 133:1984;2743-2747.
20. Ching C, Lopez C. Natural killing of Herpes Simplex virus type-1 infected target cells: normal human responses and influence of antiviral antibody. Infect Immun. 26:1979;48-56.
21. Sullivan JL, Byron KS, Brewster FE, Purtillo DT. Deficient natural killer cell activity in the X-linked lymphoproliferative syndrome. Science. 210:1980;543-544.
22. Quinnan GVJ, Kirmani N, Rook AH, Manischewitz JF, Jackson L, Moreschi G, Santos GW, Saral R, Burns WH. Cytotoxic T cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients. N Engl J Med. 307:1982;7-13.
23. Bonavida B, Katz J, Gottlieb M. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. J Immunol. 137:1986;1157-1163.
24. + subset. J Allergy Clin Immunol. 85:1990;453-459.
25. Joncas J, Monczak Y, Gibu F, Alfieri C, Bonin A, Ahronheim G, Rivard G. Brief report: killer cell defect and persistent immunological abnormalities in two patients with chronic active Epstein-Barr virus infection. J Med Virol. 28:1989;110-117.
26. Biron CA, Byron KS, Sullivan JL. Severe herpesvirus infections in an adolescent without natural killer cells. New Engl J Med. 320:1989;1731-1735.
27. Lanier LL, Spits H, Phillips JH. The developmental relationship between NK cells and T cells. Immunol Today. 13:1992;392-395.
28. Biron CA, van den Elsen P, Tutt MM, Medveczky P, Kumar V, Terhorst C. Murine natural killer cells stimulated in vivo do not express the T cell receptor α, β, T3δ, or T3ε genes. J Immunol. 139:1987;1704-1710.
29. Wang B, Biron C, She J, Higgins K, Sunshine M-J, Lacy E, Lonberg N, Terhorst C. A block in both early T lymphocyte and natural killer cell development in transgenic mice with high-copy numbers of the human CD3e gene. Proc Natl Acad Sci USA. 91:1994;9402-9406.
30. 2-microglobulin-deficient mice. J Immunol. 153:1994;5674-5681.
31. Biron CA, Welsh RM. Blastogenesis of natural killer cells during viral infection in vivo. J Immunol. 129:1982;2788-2795.
32. Biron CA, Sonnenfeld G, Welsh RM. Interferon induces natural killer cell blastogenesis in vivo. J Leuk Biol. 35:1984;31-37.
33. Biron CA, Turgiss LR, Welsh RM: Increase in NK cell number and turnover rate during acute viral infections. J Immunol 131:1539-1545.
34. Biron CA, Young HA, Kasaian M. Interleukin 2-induced proliferation of murine natural killer cells in vivo. J Exp Med. 171:1990;173-188.
35. Kasaian MT, Biron CA. Cyclosporin A inhibition of interleukin 2 gene expression, but not natural killer cell proliferation, after interferon induction in vivo. J Exp Med. 171:1990;745-762.
36. McIntyre KW, Natuk RJ, Biron CA, Kase K, Greenberger J, Welsh RM. Blastogenesis of large granular lymphocytes in nonlymphoid organs. J Leuk Biol. 43:1988;492-501.
37. Vaage JT, Fossum S, Rolstad B. Proliferation of large granular lymphocytes in the rat. Adv Exp Med Biol. 237:1988;457-461.
38. + lymphocytes during virus infection in vivo. J Immunol. 142:1989;1287-1292.
39. Kasaian MT, Biron CA. Effects of cyclosporin A on IL-2 production and lymphocyte proliferation during infection of mice with lymphocytic choriomeningitis virus. J Immunol. 144:1990;299-306.
40. + T cell expansion, and T cell IFN-γ responses during a viral infection.
41. Wiltrout RH, Pilaro AM, Gruys ME, Talmage JE, Longo DL, Ortaldo JR, Reynolds CW. Augmentation of mouse liver-associated natural killer activity by biologic response modifiers largely via recruitment of large granular lymphocytes from the bone marrow. J Immunol. 143:1989;373-378.
42. Fogler WE, Volker K, McCormick KL, Watanabe M, Ortaldo JR, Wiltrout RH. NK cell infiltration into lung, liver, and subcutaneous B16 melanoma is mediated by VCAM-1/VLA-4 interaction. of outstanding interest J Immunol. 156:1996;1714-4707 Demonstrates the role of VCAM-1/VLA-4 interactions in promoting NK cell migration to specific tissue sites after treatment with a chemical inducer of cytokines, polylCLC.
43. Orange JS, Biron CA. Characterization of early IL-12, IFN-α/β, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection. of outstanding interest J Immunol. 156:1996;4746-4756 Characterizes the dichotomy of endogenous cytokine function for NK cell regulation during MCMV infection. NK cell cytotoxicity and blastogenesis are shown to be IFN-α/β-dependent but IL-12 independent, whereas NK cell IFN-γ production is shown to be IL-12 dependent but IFN-α/β-independent.
44. Ishikawa R, Biron CA. IFN induction and associated changes in splenic leukocyte distribution. J Immunol. 150:1993;3713-3727.
45. Salazar-Mather TP, Ishikawa R, Biron CA. NK cell trafficking and cytokine expression in splenic compartments after IFN induction and viral infection. of outstanding interest J Immunol. 157:1996;3054-3064 Demonstrates dramatic leukocyte redistributions in spleen and unique NK-cell-dependent cell trafficking patterns to splenic marginal zones after endogenous IFN-α/β induction by treatment with polyl:C or after infections with MCMV or LCMV. Localization of NK cell IFN-γ mRNA expression is also shown.
46. Gresser I, Guy-Grand D, Maury C, Maunoury MT. Interferon induces peripheral lymphadenopathy in mice. J Immunol. 127:1981;1569-1575.
47. Korngold R, Blank KJ, Murasko DM. Effect of interferon on thoracic duct lymphocyte output: induction with either polyl:C or vaccinia virus. J Immunol. 130:1983;2236-2240.
48. Dunnick JK, Galasso GJ. Update on clinical trials with exogenous interferon. J Infect Dis. 142:1980;293-299.
49. Pilaro AM, Taub DD, McCormick KL, Williams HM, Sayers TJ, Fogler WE, Wiltrout RH. TNF-α is a principal cytokine involved in the recruitment of NK cells to liver parenchyma. J Immunol. 153:1994;333-342.
50. Orange JS, Wang B, Terhorst C, Biron CA. Requirement for natural killer (NK) cell-produced interferon γ in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration. J Exp Med. 182:1995;1045-1056 Presents the results of studies demonstrating NK cell IFN-γ production during MCMV infection and proving the role for this factor in NK-cell-mediated antiviral defense in the liver.
51. Tough DF, Borrow P, Sprent J. Induction of bystander T cell proliferation by viruses and type I interferon in vivo. of outstanding interest Science. 272:1996;1947-1950 Demonstrates IFN-α/β induction of memory T cell blastogenesis in vivo.
52. Bancroft GJ, Schreiber RD, Unanue ER. Natural immunity: a T-cell-independent pathway of macrophage activation, defined in scid mouse. Immunol Rev. 124:1991;5-24.
53. + T cell subsets and induces early resistance to Leishmania major in mice. J Exp Med. 178:1993;567-577.
54. Orange JS, Biron CA. An absolute and restricted requirement for IL-12 in natural killer cell IFN-γ production and antiviral defense. of outstanding interest J Immunol. 156:1996;1138-1142 Reports the detectable induction of IL-12 during MCMV but not LCMV infections, and demonstrates the role for this cytokine in activation of NK cell IFN-γ production.
55. Biron CA, Orange JS. IL12 in acute viral infectious disease. of special interest Res Immunol. 146:1995;590-600 Reviews the work on endogenous IL-12 expression and function, and on consequences of administering exogenous IL-12, during LCMV and MCMV infections.
56. Scott P. IL-12: initiation cytokine for cell-mediated immunity. Science. 260:1993;496-497.
57. Kobayashi M, Fitz L, Ryan M, Hewik RM, Clark SC, Chan S, Loudon R, Sherman F, Perussia B, Trinchieri G. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med. 170:1989;827-845.
58. Coutelier JP, Van Broeck J, Wolf SF. Interleukin-12 expression after viral infection in the mouse. J Virol. 69:1995;1955-1958.
59. Kanagat S, Thomas J, Gangappa S, Babu JS, Rouse BT. Herpes simplex virus type 1-mediated up-regulation of IL-12 (p40) mRNA expression. Implications in immunopathogenesis and protection. of special interest J Immunol. 156:1996;1110-1116 Gives results of studies evaluating IL-12 mRNA and reports detection of IL-12 protein during HSV infection.
60. + T cells. J Exp Med. 178:1993;1655-1663.
61. Manetti R, Annuziato F, Tomasevic L, Gianno V, Parronchi P, Romagnani S, Maggi E. Polyinosinic acid: polycytidylic acid promotes T helper type 1-specific immune responses by stimulating macrophage production of interferon-α and interleukin-12. of special interest Eur J Immunol. 25:1995;2656-2660 Evaluates effects of polyl:C treatment on development of Th1-type responses.
62. Heinzel FP, Rerko RM, Ling P, Hakimi J, Schoenhaut DS. Interleukin 12 is produced in vivo during endotoxemia and stimulates synthesis of gamma interferon. Infect Immun. 62:1994;4244-4249.
63. Wysocka M, Kubin M, Vieira LQ, Ozmen L, Garotta G, Scott P, Trinchieri G. Interleukin-12 is required for interferon-γ production and lethality in lipopolysaccharide-induced shock in mice. Eur J Immunol. 25:1995;672-676.
64. Orange JS, Salazar-Mather TP, Opal SM, Spencer RL, Miller AH, McEwen BS, Biron CA. Mechanism of interleukin 12-mediated toxicities during experimental viral infections: role of tumor necrosis factor and glucocorticoids. J Exp Med. 181:1995;901-914.
65. Heremans H, Dillen C, Van Damme J, Billiau A. Essential role for natural killer cells in the lethal lipopolysaccaride-induced Shwartzman-like reaction in mice. Eur J Immunol. 24:1994;1155-1160.
66. Orange JS, Wolf SF, Biron CA. Effects of IL-12 on the response and susceptibility to experimental viral infections. J Immunol. 152:1994;1253-1264.
67. Scharton-Kersten T, Afonso LCC, Wysocka M, Trinchieri G, Scott P. IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis. of special interest J Immunol. 154:1995;5320-5330 Demonstrates role for endogenous IL-12 in NK cell activation during Leishmaniasis. Also reports effects of transforming growth factor-β on NK cell IFN-γ production.
68. Cousens LP, Orange JS, Su HC, Biron CA. IFN-α/β inhibition of IL-12 and IFN-γ production in vitro and endogenously during viral infection. of outstanding interest Proc Natl Acad Sci USA. 94:1997;634-639 Identifies the selective roles for IFN-α and IFN-β in regulating SAC-induction of IL-12, and the importance of endogenously expressed IFN-α/β for regulating both virus-induction of IL-12 and lipopolysaccharide-induction of IL-12 during viral infection. Also reports the key role for IFN-α/β in inhibiting IL-12 expression during LCMV infection. These studies suggest a new mechanism playing a significant role in shaping immune responses to viral infections.
69. D'Andrea A, Aste-Amezaga M, Valiante NM, Ma X, Kubin M, Trinchieri G. Interleukin 10 (IL-10) inhibits human lymphocyte interferon γ production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med. 178:1993;1041-1048.
70. 2 on IL-12 production.
71. Karp CL, Wysocka M, Wahl LM, Ahearn JM, Cuomo PJ, Sherry B, Trinchieri G, Griffin DE. Mechanism of suppression of cell-mediated immunity by measles virus. of outstanding interest Science. 273:1996;228-231 Demonstrates that signaling through the CD46 receptor can inhibit IL-12 expression, and suggests that this mechanism contributes to immunosuppression following measles virus infections.
72. Chehimi J, Starr SE, Frank SE, D'Andrea D, Ma X, MacGregor RR, Sennelier J, Trinchieri G. Impaired interleukin 12 production in human immunodeficiency virus-infected patients. J Exp Med. 179:1994;1361-1366.
73. Von Sydow M, Sonnerborg A, Gaines H, Strannegard O. Interferon-α and tumor necrosis factor-α in serum of patients in various stages of HIV-1 infection. AIDS Res Hum Retroviruses. 7:1991;375-380.
74. Kundig TM, Schorle H, Bachmann MF, Hengartner H, Zinkernagel RM, Horak I. Immune responses in interleukin-2-deficient mice. Science. 262:1993;1059-1061.
75. 2 microglobulin.
76. Su HC, Leite-Morris KA, Braun L, Biron CA. A role for TGF-β1 in regulating natural killer cell and T lymphocyte proliferative responses during acute infection with lymphocytic choriomeningitis virus. J Immunol. 147:1991;2717-2727.
77. Su HC, Ishikawa R, Biron CA. Transforming growth factor-β expression and natural killer cell responses during virus infection of normal, nude, and SCID mice. J Immunol. 151:1993;4874-4890.
78. Nagler A, Lanier LL, Cwirla S, Phillips JH. Comparative studies of human FcRIII-positive and negative natural killer cells. J Immunol. 143:1989;3183-3191.
79. Heise MT, Virgin HW. The T cell independent role of gamma interferon and tumor necrosis factor alpha in macrophage activation during murine cytomegalovirus and herpes simplex virus infections. of special interest J Virol. 69:1995;904-909 Demonstrates macrophage activation as a result of early IFN-γ production during MCMV infection.
80. Stuehr DJ, Nathan C. Nitric oxide - a macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J Exp Med. 169:1989;1543-1555.
81. Lucin P, Jonjic S, Messerle M, Polic B, Hengel H, Koszinowski UH. Late phase inhibition of murine cytomegalovirus replication by synergistic action of interferon-gamma and tumour necrosis factor. J Gen Virol. 75:1994;101-110.
82. Karupiah G, Xie QW, Buller RM, Nathan C, Duarte C, MacMicking JD. Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase. Science. 261:1993;1445-1448.
83. Kägi D, Hengartner H. Different roles for cytotoxic T cells in the control of infections with cytopathic versus noncytopathic viruses. of special interest Curr Opin Immunol. 8:1996;472-477 Review of T-cell-mediated cytotoxicity with proposed conditions for antiviral effects of this effector mechanism.
84. Brutkiewicz RR, Welsh RM. Major histocompatibility complex class I antigens and the control of viral infections by natural killer cells. J Virol. 69:1995;3967-3971.
85. del Val M, Hengel H, Häcker H, Hartlaub U, Ruppert T, Lucin P, Koszinowsi UH. Cytomegalovirus prevents antigen presentation by blocking the transport of peptide-loaded major histocompatibility complex class I molecules into the medialgolgi compartment. J Exp Med. 176:1992;729-738.
86. Hill A, Jugovic P, York I, Russ G, Benninck J, Yewdell J, Ploegh H, Johnson D. Herpes simplex virus turns off the TAP to evade host immunity. Nature. 375:1995;411-515.
87. Wiertz EJHJ, Tortorella D, Bogyo M, Yu J, Mothes W, Jones TR, Rapoport TA, Ploegh HL. Sec 61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction. of outstanding interest Nature. 384:1996;432-438 Describes the pathway for class I downregulation by HCMV.
88. Scalzo AA, Fitzgerald NA, Wallace CR, Gibbons AE, Smart YC, Burton RC, Shellam GR. The effect of the Cmv-1 resistance gene, which is linked to the natural killer cell complex, is mediated by natural killer cells. J Immunol. 149:1992;581-589.
89. Scalzo AA, Fitzgerald NA, Simons A, La Vista AB, Shellam GR. Cmv-1, a genetic locus that controls murine cytomegalovirus replication in the spleen. J Exp Med. 171:1990;1469-1483.
90. Scalzo AA, Lyons PA, Fitzgerald NA, Forbes CA, Yokoyama WM, Shellam GR. Genetic mapping of Cmv1 in the region of mouse chromosome 6 encoding the NK gene complex-associated loci Ly49 and musNKR-P1. of outstanding interest Genomics. 27:1995;435-441 After further mapping of the Cmv-1 gene to the Ly49 and NKR-P1 complex proposes that the gene may represent an NK cell recognition structure.
91. Delano ML, Brownstein DG. Innate resistance to lethal mousepox is genetically linked to the NK gene complex on chromosome 6 and correlates with early restriction of virus replication by cells with an NK phenotype. of outstanding interest J Virol. 69:1995;5875-5877 Links ectromelia virus resistance to the NK recognition receptor complex in the mouse.